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1. Introduction 
The membrane-bound ATPase complex from 
mitochondria, chloroplasts and bacteria plays a crucial 
role in energy-transducing reactions [l-3]. One of 
the subunits from the F,,-component of this enzyme 
complex from Escherichia coli, the dicyclohexyl- 
carbodiimide (DCCD)-reactive protein, has been 
purified to homogeneity [4,5] and the amino acid 
sequence of the proteolipid has been established [6]. 
Increasing evidence exists that this subunit in oligo- 
meric,most likely hexameric, form [4,.5,7] constitutes 
a H’channel within the F,, part of the enzyme com- 
plex [8-l 11. 
Several mutant strains have been isolated from 
E. colt’ which have a defect within the ATPase com- 
plex [ 12 ,131. Of particular interest are uncB pheno- 
types in which H+-translocation through the F,, part 
is blocked even after removal of the F1 portion [12], 
and in which the proteolipid does no longer react 
with DCCD. In a second type of mutant (DCCD- 
resistant strains) the inhibition of the ATPase activity 
can only be achieved with elevated levels of DCCD 
[ 14,151. Therefore, it seemed promising to us that 
the characterization of those mutant proteolipids 
might give us some hints, which residues are necessary 
for the translocation of H’ through F,,, leading to a 
better understanding of the molecular mechanism of 
H’ translocation. 
We have recently isolated and characterized the 
DCCD-reactive proteins from an uncB mutant (DC 7/ 
10) and a DCCD-resistant strain (DC 1) [ 161. We now 
describe the amino acid sequence of these mutant 
proteolipids. The data are in full agreement with our 
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earlier suggestion that the DCCD-reactive aspartyl 
residue in position 6 1 of the polypeptide chain is 
replaced by a glycine residue in the mutant proteo- 
lipid from the uncB phenotype. In the DC1 protein 
an isoleucine/valine replacement occurred at posi- 
tion 28. 
2. Materials and methods 
2.1. Bacterial strains and growth conditions 
E. coli K12 Y,,(h), F- (lack, fadR, but12, rha, 
ilv, metE), and its derivatives, the uncB type mutant 
DC 7/10 and the DCCD- resistant strain DC1 , were 
kindly supplied by Dr H. U. Schairer [12,14]. These 
strains were grown in a minimal medium [5] supple- 
mented with isoleucine, valine and methionine 
(0.1 mg/ml each) with 1% glucose as the carbon 
source. Cells were obtained from 200 1 and 3000 1 
cultures grown to late log phase. 
2.2. Isolation and purification of the proteolipids 
The ATPase proteolipid was extracted from intact 
cells on a large scale with chloroform/methanol (2: 1) 
as described previously [ 161. Purification to homoge- 
neity was achieved by DEAEcellulose or CM-cellulose 
chromatography [5 ,161. Minor contaminants, occa- 
sionally present in the proteolipid fraction from the 
ion exchange column, could be removed successfully 
by chromatography on Sephadex LH-60 [5,16]. 
2.3. Separation and characterization of fragment 
pep tides 
Amino acid analysis of the protein fragment 
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peptides was performed after hydrolysis of suitable 
aliquots of protein with 5.7 N HCl at 160°C for 30, 
60,and 180 min (Durrum D-500,Palo Alto). Cyanogen 
bromide (CNBr)-cleavage was carried out with 
200-500 nmol protein in 0.4-l .O ml concentrated 
formic acid (Merck, Darmstadt), 1 M in CNBr (Serva, 
Heidelberg). The concentration of the formic acid was 
lowered to 80% by addition of 0.1-0.25 ml water. 
The reaction was allowed to proceed for 24 h at room 
temperature in the dark. After evaporation of the 
reaction mixture the fragment peptides were redis- 
solved in 80% formic acid and size-fractionated on a 
column of Bio-Gel P-30 minus 400 mesh (Bio-Rad, 
Gauting/Mtinchen) with 80% formic acid as eluant . 
Column effluents were continuously monitored at 
280 nm and by differential refractometry (Waters 
R 401, Konigstein). The eluted peptides were further 
characterized by end group determination with dansyl 
chloride [17]. 
2.4. Immobilization of peptides to activated porous 
glass 
The homoserine peptides generated by CNBr- 
cleavage were lactonized by a 10 min treatment at 
56°C with anhydrous trifluoro-acetic acid. After 
evaporation of the trifluoroacetic acid in a desiccator 
over KOH pellets, the corresponding homoserine 
lactone peptides were dissolved in 0.6 ml dimethyl- 
formamide, mixed with 200 mg of 3-aminopropyl 
glass and supplemented with 0.01 ml triethylamine. 
The mixture was kept overnight at 56°C [ 181. The 
automated Edman degradation was performed with a 
home-built solid-phase sequencer. The degradation 
program, the processing of the released thiazolinones, 
is described in detail elsewhere [ 191. The amino acid 
phenylthiohydantoins were identified by gas-chro- 
matography (Shimadzu GC 6A FPD) and/or by 
multiple ion programmed mass spectrometry in elec- 
tron impact mode (Finnigan 3200, Mtinchen). 
3. Results 
Mutants of the uncB type (DG 7/10) are classified 
according to the following criteria: the mutation maps 
between asn and ilv in the uncA,B region of the 
E. coli chromosome [ 131, The mutants contain an 
enzymatically active Fr component, but no functional 
Table 1 
Amino acid composition of the DCCD-reactive proteins from wild type and 
mutant strains of E. coli and of the CNBr fragments B6 
Amino 
acid K12 
Molar ratios B6 
DG 7/10 DC1 K12 DC 1 
Asp 
Thr 
Hse 
Glu 
Pro 
GlY 
Ala 
Val 
Met 
5.0 (5) 4.1 (4) 5.1 (5) (1) 
1.1 (1) 1.1 (1) 1.1 (1) (1) 
- (0) (0) 
-4.3 (4) 
- (0) (1) 
4.2 (4) 4.3 (4) (3) 
3.0 (3) 3.0 (3) 3.2 (3) (2) 
10.0 (10) 10.8 (11) 10.1 (IO) (7) 
12.8 (13) 13.0 (13) 12.8 (13) (6) 
6.1 (6) 6.1 (6) 62 (I) (1) 
7.7 (8) 7.7 (8) 7.7 (8) (0) 
Ile 7.9 (8) 7.9 (8) 62 (I) (6) 
Leu 12.1 (12) 12.2 (12) 12.1 (12) (6) 
TY~ 2.0 ‘(2j 2.0 ‘(2j 1.8 ‘(2j (0) - ioj 
Phe 3.9 (4) 3.9 (4) 4.0 (4) (3) 2.8 (3) 
LYS 1.0 (1) 1.0 (1) 1.0 (1) (1) 0.9 (1) 
Arg 2.1 (2) 2.1 (2) 2.0 (2) (2) 2.1 (2) 
Total 
residues 79 79 79 40 40 
I .3 (1) 
1 .o (1) 
I .o (1) 
2.9 (3) 
2.3 (2) 
6.6 (7) 
6.1 (6) 
L8 (2, 
- (0) 
4.5 (5) 
6.0 (6) 
Serine, cysteine, histidine and tryptophan are missing. The integers in parentheses 
are deduced from sequence analysis. Changes in amino acid composition of the 
mutant peptides are underlined 
266 
Volume 113. number 2 FEBS LETTERS May 1980 
10 20 
f-Mt-G1u-Asn-Leu-Asn-Met-AapLeu-Leu-Tyr-Met-Ala-Ala-Ala-Val-Met-Met-Gly-Leu-Ala-Ala-Ile-Gly-Ala-Ala-Ile- 
.s,,._ _ -_B2_--_,._ -_ - B3___:~~____B,___, .e5,.__ - --- B6_ - - -- - - --- 
30 40 50 
Gly-Ile-Gly-Ile-Leu-Gly-Gly-Lys-Phe-Leu-Glu-Gly-Ala-Ala-Arg-Gln-Pro-Aap-Leu-Ile-Pro-Leu-Leu-Arg-Thr-Gln- 
_____-___-----__------BC--__-_-----_---------~~- -------_ 
60 70 79 
Phe-Phe-Ile-Val-Met-Gly-Leu-Val-A~~Ala-Ile-Pro-Met-Ile-Ala-Val-Gly-Leu-Gly-Leu-Tyr-Val-Met-Phe-Ala-Val-Ala 
___86_____,~-~~~_~B,----.-~~+---~~--~B6-----~~-- -D4- - - B9 - -, 
Fig.1. Amino acid sequence of the proteolipid from E. coli wild type K12. The arrows indicate the location of CNBr-peptides. 
FO. We have reported that in the case of the uncB 
mutant DC 7/l, the inability to bind DCCD is not 
due to the absence of the proteolipid in the F0 part, 
but had to be explained by a modification of this 
protein [20]. The latter fact also holds for the mutant 
DC 7/10 [16]. The DCCD-resistant strain DC1 has a 
functional Fo as well as F1 part. However, the inhibi- 
tion of the ATPase activity is impaired [ 141, indicating 
minor changes within the proteolipid. 
The amino acid composition of wild type and 
mutant strains are given in table 1. Compared with 
the wild type, the proteolipid of mutant DG 7/10 
contained one more glycine and one aspartic acid 
residue is missing. In the case of the mutant DC1 a 
valine residue seems to have replaced an isoleucine. 
By CNBr-treatment the proteins were cleaved into 
various fragments. This is shown for the wild type in 
fig.1. The fragment B6, comprising the residues from 
I 
Jle 
K-12 
GIy 
27 
_J 
1 
1 
I Val 
DC-l 
Jle 
Ile 
I, 
Fig.2. Gas-chromatograms of the phenylthiohydantoins derived from the Edman degradation of the CNBr-peptide B6 from wild 
type proteolipid (upper part) and the DC1 mutant proteolipid (lower part) (Shimadzu GC 6A FPD; flame photometric sulfur sen- 
sitive detector; isothermal run at 2 10°C; liquid phase: PTH-Chrom-S (Serva, Heidelberg)). Arrows indicate injection points. 
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Gly’8. . . Mets7, is by far the largest. Consequently, 
it could be separated easily from the other fragments 
by gel chromatography (data not shown). The 
N-terminal group and the amino acid composition of 
the fragments were determined systematically by the 
dansylation technique and amino acid analysis, 
respectively. Comparison of the amino acid composi- 
tion of fragment B6 from the wild type with that of 
mutant DC1 revealed the isoleucine/valine exchange 
(table 1, last two columns). The isolated fragment B6 
of mutant DC1 was immobilized and subsequently 
degraded. Fig.2 shows the significant part of the gas- 
chromatography (CC) traces of mutant and wild type 
degradation products. Although the quantities of 
phenylthiohydantoins obtained are slightly different 
for the two peptides, the marked difference in posi- 
tion 28 is obvious. All the other GC-traces of the 
various mutant peptides revealed no remarkable differ- 
ences as compared with the wild type peptides. 
The investigation of the CNBr-peptides of the 
II 
Valso 
proteolipid from DG 7/10 was focussed from the very 
beginning on fragment B7 (fig.1). The inability to 
bind DCCD, and the replacement of one aspartic acid 
residue by glycine strongly suggested an exchange at 
position 6 1. Similar as in the case of the wild type 
[21] the chromatography of the mutant fragments 
on Bio-Gel P-30 resulted only in a partial separation 
of the octapeptide B7 (Glys8. . . Met6’) and the 
decapeptide B8 (Ile66. . . Met”) (data not shown). 
Nevertheless, our experience with the wild type pro- 
tein [21] encouraged us to perform the Edman 
degradation with the peptide mixture, thus avoiding 
material-consuming and laborious purification steps. 
Fig.3 shows the significant parts of the GC-traces 
monitoring the degradation products starting with 
residue Gly’a until Ala6’ for the wild type as well as 
the mutant peptide mixture. From the upper part of 
fig.3 (wild type) it can be deduced that the sequence 
Leu59-Val-ASP-Ala62 of fragment B7 is accompanied 
by Ala67-Val-GLY-Leu70 of fragment B8. By contrast, 
K- 12 
Ala6* I . (Leu’O) 
WaP) 
; Va160 
DG-T/lo 
(GlyeQ) 
Fig.3. Gaschromatograms of the phenylthiohydantoins derived from the Edman degradation of the CNBr-peptide B7 contami- 
nated with B8 from wild type proteolipid (upper part) and of the DC 7/10 mutant proteolipid (lower part). For experimental 
conditions see fig.2 with the following exception: The support was coated with SP-400 for differentiation of Val- and Gly- 
phenylthiohydantoin. The residues in parenthesis are according to the contaminating peptide B8 (see fig.1). Arrows indicate iqec- 
tion points. The figures beneath the CC-traces correlate to Edman degradation steps. 
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the mutant sequence Leu 59-Val-GLY-Ala62 is accom- 
panied by the identical sequence Ala6’-Val-GLY-Leu”’ 
(fig.3, lower part). It may seem difficult to differen- 
tiate the Gly” of the mutant peptide from the con- 
taminating sequence in which Gly69 occurs at the 
same degradation step. However, the absence of an 
aspartic acid methylester phenylthiohydantoin 
as well as a quantitative determination of the glycine 
phenylthiohydantoin corresponding to position 61 
firmly proves the altered sequence. All the other frag- 
ments had amino acid compositions and end groups, 
identical to that of the wild type. 
A comparison of the CNBr-fragment patterns from 
the Bio-Gel P-30 of the mutant protein with that of 
the wild type revealed that, especially in the case of 
DG 7/10, small but reproducible differences in the 
cleavage yields were observed (data not shown). At 
the moment, it is rather speculative, to interpret such 
an observation in terms of changes in the protein con- 
fornation. 
4. Discussion 
The AspfGlyexchange in the proteolipid of the 
uncB mutant DG 7110 was established to occur at the 
site which is exclusively responsible for the binding of 
the inhibitor DCCD in the wild type protein. This 
fmding strongly supports the notion that the carboxyl 
group of the aspartyl residue at position 61 of the 
peptide chain is directly involved in the H+-transloca- 
tion mech~ism. Further support for this view stems 
from sequence analyses of proteolipids derived from 
different sources [22]. With the exception of the 
E. coli proteolipid (Asp-Ala), this site is conserved by 
the sequence Glu-Ala in all organisms investigated so 
far. Recently, the proteolipid from a similar (or per- 
haps identical) uncB mutant (DG 7/l) of E. coli has 
been characterized. An identical amino acid replace- 
ment was found [23]. 
The Ile/Val replacement of the DC1 proteolipid 
was identified at position 28 (fig.1). Unlike in oligo- 
myc~-resistant mutants from ~e~~o~~o~~ crassa and 
~aec~aro~yee~ c revisiae [6] the replacement occurs 
at a location rather distant from the DCCD-reactive 
site, at least in terms of primary structure. Nevertheless, 
it is conceivable that in the native conformation this 
residue might be in close vicinity to the DCCD-reac- 
tive site. This view would point to a sterical influence 
between these sites giving rise to the impaired reactivity 
towards DCCD at the aspartyl residue. Finally, it is 
interesting to note that the replacement of isoleucine 
by a less bulky hydrophobic amino acid residue causes 
such a pronounced effect. 
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